Showing results (251-260 of 2,105) with videos related to
Sort By:
Pageof 211
CNS Drugs|July 23, 2021
Impact of CNS Stimulants for Attention-Deficit/Hyperactivity Disorder on Growth: Epidemiology and Approaches to Management in Children and AdolescentsRaman Baweja, Daniel E Hale, James G WaxmonskyCNS Drugs|December 5, 2020
Evaluation of Prescription Practices of Domperidone in Parkinson's Disease: A Cross Sectional Study Among French NeurologistsDiane Lastennet, Louise-Laure Mariani, Olivier Rascol, et al.CNS Drugs|November 20, 2012
Methylphenidate : a treatment for Parkinson's disease?David Devos, Caroline Moreau, Arnaud Delval, et al.CNS Drugs|November 20, 2012
CSF penetration by antiretroviral drugsChristine Eisfeld, Doris Reichelt, Stefan Evers, et al.CNS Drugs|November 20, 2012
Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorderJose Martinez-Raga, Carlos Knecht, Nestor Szerman, et al.CNS Drugs|May 16, 2013
The long-term safety of antiepileptic drugsAthanasios Gaitatzis, Josemir W SanderCNS Drugs|May 9, 2013
Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidenceJerome Sarris, Erica McIntyre, David A CamfieldCNS Drugs|March 14, 2013
Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatmentChristopher R Bailey, Elisabeth Cordell, Sean M Sobin, et al.CNS Drugs|December 13, 2012
Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled studyAmirhossein Modabbernia, Farzin Rezaei, Bahman Salehi, et al.Pageof 211